Insulinoma in tuberous sclerosis

References

1. 1.↵
   1. Moyer A,
   2. Naglieri C,
   3. Elsbury K.
   4. Garima Poddar

   1. Brunicardi FC,
   2. Andersen DK,
   3. Billiar TR,
   4. Dunn DL,
   5. Kao LS.
   6. Hunter JG, et al.

   Schwartz’s principles of surgery, 11th ed. In: Moyer A, Naglieri C, Elsbury K. Garima Poddar, editors. New York: McGraw-Hill; 2019.
2. 2.↵
   1. Dworakowska D,
   2. Grossman AB.

   Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer 2009; 16: 45–58.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Kang MY,
   2. Yeoh J,
   3. Pondicherry A,
   4. Rahman H,
   5. Dissanayake A.

   Insulinoma and tuberous sclerosis: a possible mechanistic target of rapamycin (mTOR) Pathway Abnormality? J Endocr Soc 2017; 1: 1120–1123.

   OpenUrl
4. 4.↵
   1. Orlova KA,
   2. Crino PB.

   The tuberous sclerosis complex. Ann N Y Acad Sci 2010; 1184: 87–105.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Comninos AN,
   2. Yang L,
   3. Abbara A,
   4. Dhillo WS,
   5. Bassett JH,
   6. Todd JF.

   Frequent falls and confusion: recurrent hypoglycemia in a patient with tuberous sclerosis complex. Clin Case Rep 2018; 6: 904–909.

   OpenUrl
6. 6.↵
   1. Francalanci P,
   2. Diomedi-Camassei F,
   3. Purificato C,
   4. Santorelli FM,
   5. Giannotti A,
   6. Dominici C, et al.

   Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol 2003; 27: 1386–1389.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Khamzina L,
   2. Veilleux A,
   3. Bergeron S,
   4. Marette A.

   Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005; 146: 1473–1481.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Eledrisi MS,
   2. Stuart CA,
   3. Alshanti M.

   Insulinoma in a patient with tuberous sclerosis: is there an association? Endocr Pract 2002; 8: 109–112.

   OpenUrlPubMed
9. 9.↵
   1. Shin JJ,
   2. Gorden P,
   3. Libutti SK.

   Insulinoma: pathophysiology, localization and management. Future Oncol 2010; 6: 229–237.

   OpenUrlCrossRefPubMed
10. 10.
    1. Gutman A,
    2. Leffkowitz M.

    Tuberous sclerosis associated with spontaneous hypoglycaemia. BMJ 1959; 2: 1065–1068.

    OpenUrlFREE Full Text
11. 11.
    1. Davoren PM,
    2. Epstein MT.

    Insulinoma complicating tuberous sclerosis. J Neurol Neurosurg Psychiatry 1992; 55: 1209.

    OpenUrlFREE Full Text
12. 12.
    1. Kim H,
    2. Kerr A,
    3. Morehouse H.

    The association between tuberous sclerosis and insulinoma. Am J Neuroradiol 1995; 16: 1543–1544.

    OpenUrlAbstract
13. 13.
    1. Boubaddi NE,
    2. Imbert Y,
    3. Tissot B,
    4. Chapus JJ,
    5. Dupont E,
    6. Gallouin D, et al.

    Secreting insulinoma and Bourneville’s tuberous sclerosis. Gastroenterol Clin Biol 1997; 21: 343.

    OpenUrlPubMedWeb of Science